Literature DB >> 30255472

Physicochemical and In Vitro Evaluation of Drug Delivery of an Antibacterial Synthetic Benzophenone in Biodegradable PLGA Nanoparticles.

Gabriella Costabile1, Kathrin I Gasteyer2, Venkatereddy Nadithe2, Katherine Van Denburgh2, Qian Lin2, Shiv Sharma2, Joshua J Reineke3, Steven M Firestine2, Olivia M Merkel4,5.   

Abstract

Due to the increasing incidents of antimicrobial-resistant pathogens, the development of new antibiotics and their efficient formulation for suitable administration is crucial. Currently, one group of promising antimicrobial compounds are the benzophenone tetra-amides which show good activity even against gram-positive, drug-resistant pathogens. These compounds suffer from poor water solubility and bioavailability. It is therefore important to develop dosage forms which can address this disadvantage while also maintaining efficacy and potentially generating long-term exposures to minimize frequent dosing. Biodegradable nanoparticles provide one solution, and we describe here the encapsulation of the experimental benzophenone-based antibiotic, SV7. Poly-lactic-co-glycolic-acid (PLGA) nanoparticles were optimized for their physicochemical properties, their encapsulation efficiency, sustained drug release as well as antimicrobial activity. The optimized formulation contained particles smaller than 200 nm with a slightly negative zeta potential which released 39% of their drug load over 30 days. This formulation maintains the antibacterial activity of SV7 while minimizing the impact on mammalian cells.

Entities:  

Keywords:  PLGA nanoparticles; benzophenone antibiotics; poorly water-soluble drug; sustained release

Mesh:

Substances:

Year:  2018        PMID: 30255472     DOI: 10.1208/s12249-018-1187-9

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  1 in total

1.  Nano-encapsulation and characterization of baricitinib using poly-lactic-glycolic acid co-polymer.

Authors:  Mohammad Javed Ansari; Saad M Alshahrani
Journal:  Saudi Pharm J       Date:  2019-01-12       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.